---
figid: PMC5893801__fcell-06-00038-g0001
figlink: /pmc/articles/PMC5893801/figure/F1/
number: F1
caption: Potential therapeutic strategies to enhance immune checkpoint inhibitors
  by targeting tumor-associated macrophages (TAM). (A) Cytotoxicity of CD8+ T cell
  in the tumors is suppressed by immune checkpoint pathways activated by cancer cells
  and TAM. TAM also suppresses CD8+ T cell functions via checkpoint pathway independent
  mechanisms that are still under investigation. (B) Blockade of immune checkpoint
  pathway by antibodies for CTLA4, PD1, and PD-L1 enhances CD8+ T cell cytotoxicity.
  However, immune suppressive tumor microenvironment, especially TAM in it, will limit
  the anti-tumor efficacy of the checkpoint inhibitors. (C) Therapeutic efficacy of
  checkpoint inhibitors can be improved by TAM targeting through different strategies,
  i.e., TAM depletion (left), TAM reprogramming (central), and targeting functional
  molecules of TAM (right). MΦ means macrophage.
pmcid: PMC5893801
papertitle: Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance
  the Response to Immune Checkpoint Inhibitors.
reftext: Luca Cassetta, et al. Front Cell Dev Biol. 2018;6:38.
pmc_ranked_result_index: '46799'
pathway_score: 0.9505464
filename: fcell-06-00038-g0001.jpg
figtitle: Therapeutic strategies to enhance immune checkpoint inhibitors by targeting
  tumor-associated macrophages (TAM)
year: '2018'
organisms:
- Homo sapiens
ndex: c84aaf4a-deeb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5893801__fcell-06-00038-g0001.html
  '@type': Dataset
  description: Potential therapeutic strategies to enhance immune checkpoint inhibitors
    by targeting tumor-associated macrophages (TAM). (A) Cytotoxicity of CD8+ T cell
    in the tumors is suppressed by immune checkpoint pathways activated by cancer
    cells and TAM. TAM also suppresses CD8+ T cell functions via checkpoint pathway
    independent mechanisms that are still under investigation. (B) Blockade of immune
    checkpoint pathway by antibodies for CTLA4, PD1, and PD-L1 enhances CD8+ T cell
    cytotoxicity. However, immune suppressive tumor microenvironment, especially TAM
    in it, will limit the anti-tumor efficacy of the checkpoint inhibitors. (C) Therapeutic
    efficacy of checkpoint inhibitors can be improved by TAM targeting through different
    strategies, i.e., TAM depletion (left), TAM reprogramming (central), and targeting
    functional molecules of TAM (right). MΦ means macrophage.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SIRT1
  - HDAC2
  - SIRT3
  - SIRT2
  - CD8B
  - HDAC6
  - HDAC5
  - HDAC1
  - HDAC11
  - SIRT4
  - SIRT7
  - PDCD1
  - SIRT5
  - HDAC7
  - HDAC8
  - CD80
  - CD86
  - CSF1R
  - HDAC9
  - HDAC4
  - MARCO
  - CD274
  - PDCD1LG2
  - CD8A
  - SIRT6
  - ARG1
  - HDAC10
  - HDAC3
  - TAM
genes:
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC6
  entrez: '10013'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC5
  entrez: '10014'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC11
  entrez: '79885'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT7
  entrez: '51547'
- word: PD1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT5
  entrez: '23408'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC7
  entrez: '51564'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: CD80
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: CD86,
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: CSF1R
  symbol: CSF1R
  source: hgnc_symbol
  hgnc_symbol: CSF1R
  entrez: '1436'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC9
  entrez: '9734'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC4
  entrez: '9759'
- word: MARCO
  symbol: MARCO
  source: hgnc_symbol
  hgnc_symbol: MARCO
  entrez: '8685'
- word: PD-L1/PD-L2
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PD-L1/PD-L2
  symbol: PD-L2
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1LG2
  entrez: '80380'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: ARG1
  symbol: ARG1
  source: hgnc_symbol
  hgnc_symbol: ARG1
  entrez: '383'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC10
  entrez: '83933'
- word: HDAČ
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
chemicals:
- word: TAM
  source: MESH
  identifier: C419191
diseases: []
figid_alias: PMC5893801__F1
redirect_from: /figures/PMC5893801__F1
figtype: Figure
---
